⌘K

Login Start Free

Home/Filings/5/0001493152-23-015782

5//SEC Filing

File Justin J. 5

Accession 0001493152-23-015782

CIK 0001618835other

View on SEC.gov Company Profile

Filed

May 7, 8:00 PM ET

Accepted

May 8, 4:05 PM ET

Size

5.0 KB

Accession

0001493152-23-015782

Insider Transaction Report

Form 5

Period: 2022-12-31

Evofem Biosciences, Inc.EVFM

Chief Financial Officer

Transactions

Disposition to Issuer
Common Stock
2022-12-31−30,000→ 24,065 total

Footnotes (1)

[F1]The disposition is due to forfeiture under the vesting provisions of restricted stock awards granted on 2/18/2022.

Documents

1 file

5
ownership.xmlPrimary

Issuer

Evofem Biosciences, Inc.

CIK 0001618835

Entity typeother

Related Parties

1

filerCIK 0001726277

Filing Metadata

Form type: 5
Filed: May 7, 8:00 PM ET
Accepted: May 8, 4:05 PM ET
Size: 5.0 KB

View on SEC.gov